{{Rsnum
|rsid=11037575
|Gene=HSD17B12
|Chromosome=11
|position=43706780
|Orientation=plus
|GMAF=0.4527
|Gene_s=HSD17B12
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 18.6 | 42.5 | 38.9
| HCB | 56.2 | 38.0 | 5.8
| JPT | 53.1 | 37.2 | 9.7
| YRI | 1.4 | 25.9 | 72.8
| ASW | 1.8 | 26.3 | 71.9
| CHB | 56.2 | 38.0 | 5.8
| CHD | 45.9 | 47.7 | 6.4
| GIH | 13.9 | 49.5 | 36.6
| LWK | 0.9 | 20.0 | 79.1
| MEX | 24.1 | 48.3 | 27.6
| MKK | 1.9 | 30.1 | 67.9
| TSI | 7.8 | 47.1 | 45.1
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22941191
  |Trait=Neuroblastoma
  |Title=Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.
  |RiskAllele=C
  |Pval=5E-8
  |OR=1.23
  |ORtxt=[NR]
  |OA=1
}}

{{PMID Auto
|PMID=18463370
|Title=Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.
|OA=1
}}

{{PMID Auto
|PMID=21436895
|Title=Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}